Clinical Trial

Assessment of Adherence to Remotely Monitored Physical Activity Tracked on a Smartwatch, and Its Impact on Reducing Fatigue 3 Months After Adjuvant Chemotherapy for Cancer

Study acronym: WATCH AND ACT
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
A single-center, randomized (1:1) open-label, prospective, stratified study with two parallel arms, designed to evaluate adherence to the adapted physical activity (APA) program for patients participating in an APA program and to compare changes in fatigue at 3 months in patients who have completed adjuvant systemic chemotherapy for cancer and are participating in an APA program.
Trial Details
NCT Number NCT07429487
Lead Sponsor Centre Antoine Lacassagne
Collaborators: Centre Hospitalier Universitaire de Nice
Conditions Breast Cancer, Colorectal Cancer, Ovarian Adenocarcinoma, Pancreatic Cancer, Gastric Adenocarcinoma
Enrollment 98 participants
Start Date 2026-06-15
Primary Completion 2029-09-15 (estimated)
Study Completion 2030-06-15 (estimated)
Updated on ClinicalTrials.gov 2026-02-24